- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myeloid Leukemia in New Zealand
Total 2312 results
-
University of BirminghamAssistance Publique - Hôpitaux de Paris; Pfizer; Cancer Research UK; National Cancer...RecruitingAcute Myeloid LeukaemiaFrance, Switzerland, United Kingdom, New Zealand, Australia, Ireland
-
University of SydneyMelbourne Health; Royal Brisbane and Women's HospitalUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaFrance, United States, Australia
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
SanofiTerminatedAcute Myeloid LeukaemiaUnited States
-
GlaxoSmithKlineTerminatedLeukaemia, Myelocytic, AcuteUnited States, Australia, Canada
-
Antisoma ResearchTerminatedAcute Myeloid LeukemiaUnited States, Taiwan, Australia, New Zealand
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
Vastra Gotaland RegionAustralasian Leukaemia and Lymphoma Group; The Canadian Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaFinland, Australia, Canada, New Zealand, Sweden, Estonia, Germany, Greece, Norway
-
Otsuka Australia Pharmaceutical Pty LtdRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient PreferenceNew Zealand, Australia
-
Antisoma ResearchCompletedLeukemia, MyeloidUnited States, New Zealand
-
Aptose Biosciences Inc.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States, Germany, Spain, Korea, Republic of, Australia, New Zealand
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteUnited States, France
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Myeloid LeukemiaUnited States
-
Weill Medical College of Cornell UniversityTerminatedAcute Myeloid Leukemia (AML)United States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)United States, Australia, France, Spain
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Yale UniversityPfizerTerminatedACUTE MYELOID LEUKEMIAUnited States
-
Hoffmann-La RocheTerminated
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Celularity IncorporatedTerminated
-
PfizerCompletedLeukemia, Myeloid, AcuteUnited States
-
Memorial Sloan Kettering Cancer CenterTerminatedAcute Myeloid Leukemia (AML)United States
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory | Relapsed Acute Myeloid LeukemiaUnited States
-
Yale UniversityVanderbilt UniversityCompletedRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsTerminatedPhilidelphia Positive Chronic Myeloid LeukaemiaAustralia
-
ImmunoGen, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States
-
medac GmbHSynteract, Inc.RecruitingMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML) | Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)United States
-
Chroma TherapeuticsUnknownAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Leukemia Cutis | Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLUnited States
-
Sumitomo Pharma America, Inc.TerminatedAcute Myeloid Leukemia (AML)United States
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Yale UniversityBristol-Myers Squibb; National Cancer Institute (NCI)WithdrawnAcute Myeloid LeukemiaUnited States
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
Weill Medical College of Cornell UniversityPfizer; Jazz PharmaceuticalsTerminatedAcute Myeloid LeukemiaUnited States
-
Hoffmann-La RocheCompleted
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
AbbVieAstellas Pharma Inc; Genentech, Inc.CompletedAcute Myeloid Leukemia (AML)United States
-
Genentech, Inc.Completed
-
OrphAI TherapeuticsCompletedAcute Myeloid Leukemia | OncologyUnited States
-
Hoffmann-La RocheTerminatedLeukemia, Myeloid, AcuteItaly, Korea, Republic of, Belgium, Australia, United States, Canada, United Kingdom, Spain, Netherlands, France, Germany, New Zealand, Israel, Norway, Russian Federation, Switzerland, Austria, Finland, Panama
-
Columbia UniversityThe Leukemia and Lymphoma SocietyCompletedAcute Myeloid LeukemiaUnited States
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Hetty CarrawayActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedAcute Myeloid LeukemiaUnited States
-
SanofiTerminatedMyeloid LeukemiaUnited States, France, Spain